Literature DB >> 18094953

Mast cells and immunological skin diseases.

Daniel Navi1, Jun Saegusa, Fu-Tong Liu.   

Abstract

Mast cells play an important role in both adaptive and innate immunity, and a large body of literature demonstrates their functions in skin immunity. This article reviews the literature on the role of this cell type in the pathogenesis of a number of immunological skin diseases, including contact dermatitis, atopic dermatitis, immunobullous disease, scleroderma, and chronic graft-vs.-host disease. In all these diseases, mast cells are noted to increase in number and undergo degranulation in the affected skin, and in some cases, their specific mediators are detected. Elucidation of the contribution of mast cells to the pathogenesis of these diseases has been aided significantly by the use of animal models, especially mouse models. The studies of mast cell-deficient mice in conjunction with normal congenic mice have been particularly fruitful, although in some cases, such as contact dermatitis, a definitive conclusion has not been achieved despite extensive efforts. The role of mast cells in atopic dermatitis has also been suggested by studies of gene polymorphism, which have linked some of the mast cell-related genes to the disease. In the case of scleroderma and chronic graft-vs.-host disease, the function of mast cells in fibrosis is further supported by the ability of these cells and their mediators to induce activation and proliferation of fibroblasts. Therapies targeting mast cells may prove beneficial for treatment of these inflammatory and autoimmune diseases.

Entities:  

Mesh:

Year:  2007        PMID: 18094953     DOI: 10.1007/s12016-007-0029-4

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  127 in total

1.  An eosinophil chemotactic factor present in blister fluids of bullous pemphigoid patients.

Authors:  T Baba; H Sonozaki; K Seki; M Uchiyama; Y Ikesawa; M Toriisu
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

Review 2.  Mast cells and fibrosis. The relevance to scleroderma.

Authors:  H N Claman
Journal:  Rheum Dis Clin North Am       Date:  1990-02       Impact factor: 2.670

3.  Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient.

Authors:  A M Dvorak; M C Mihm; J E Osage; T H Kwan; K F Austen; B U Wintroub
Journal:  J Invest Dermatol       Date:  1982-02       Impact factor: 8.551

4.  T cells and mast cells as a major source of interleukin-13 in atopic dermatitis.

Authors:  Wataru Obara; Yoko Kawa; Chisei Ra; Kusuki Nishioka; Yoshinao Soma; Masako Mizoguchi
Journal:  Dermatology       Date:  2002       Impact factor: 5.366

5.  Peptide analogs that inhibit IgE-Fc epsilon RI alpha interactions ameliorate the development of lethal graft-versus-host disease.

Authors:  R Korngold; B A Jameson; J M McDonnell; C Leighton; B J Sutton; H J Gould; G F Murphy
Journal:  Biol Blood Marrow Transplant       Date:  1997-10       Impact factor: 5.742

6.  Mast cell "disappearance" in chronic murine graft-vs-host disease (GVHD)-ultrastructural demonstration of "phantom mast cells".

Authors:  H N Claman; K L Choi; W Sujansky; A E Vatter
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

7.  Chronic graft-versus-host disease (GVHD) as a model for scleroderma. I. Description of model systems.

Authors:  B D Jaffee; H N Claman
Journal:  Cell Immunol       Date:  1983-04-01       Impact factor: 4.868

8.  Cutaneous mast cell depletion and recovery in murine graft-vs-host disease.

Authors:  K L Choi; R Giorno; H N Claman
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

9.  Rat peritoneal mast cells present antigen to a PPD-specific T cell line.

Authors:  C C Fox; S D Jewell; C C Whitacre
Journal:  Cell Immunol       Date:  1994-10-01       Impact factor: 4.868

10.  Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis?

Authors:  R A Hawkins; H N Claman; R A Clark; J C Steigerwald
Journal:  Ann Intern Med       Date:  1985-02       Impact factor: 25.391

View more
  18 in total

1.  Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells.

Authors:  Sheela Shrestha; Barry Wershil; John F Sarwark; Timothy B Niewold; Teresa Philipp; Lauren M Pachman
Journal:  Arthritis Rheum       Date:  2010-09

Review 2.  New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action?

Authors:  Margaret E Walker; Julianne K Hatfield; Melissa A Brown
Journal:  Biochim Biophys Acta       Date:  2011-02-25

3.  [Chronic pruritus in autoimmune dermatoses : results of a comparative survey].

Authors:  L Schröder; M Hertl; E Chatzigeorgakidis; N Q Phan; S Ständer
Journal:  Hautarzt       Date:  2012-07       Impact factor: 0.751

4.  Redefinition of the human mast cell transcriptome by deep-CAGE sequencing.

Authors:  Efthymios Motakis; Sven Guhl; Yuri Ishizu; Masayoshi Itoh; Hideya Kawaji; Michiel de Hoon; Timo Lassmann; Piero Carninci; Yoshihide Hayashizaki; Torsten Zuberbier; Alistair R R Forrest; Magda Babina
Journal:  Blood       Date:  2014-03-26       Impact factor: 22.113

Review 5.  A modular view of cytokine networks in atopic dermatitis.

Authors:  Irit Carmi-Levy; Bernhard Homey; Vassili Soumelis
Journal:  Clin Rev Allergy Immunol       Date:  2011-12       Impact factor: 8.667

6.  IgE-mediated mast cell responses are inhibited by thymol-mediated, activation-induced cell death in skin inflammation.

Authors:  Joshua B Wechsler; Chia-Lin Hsu; Paul J Bryce
Journal:  J Allergy Clin Immunol       Date:  2014-01-31       Impact factor: 10.793

7.  Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment.

Authors:  Shadmehr Demehri; Ahu Turkoz; Raphael Kopan
Journal:  Cancer Cell       Date:  2009-07-07       Impact factor: 31.743

8.  Auf1/Hnrnpd-deficient mice develop pruritic inflammatory skin disease.

Authors:  Navid Sadri; Robert J Schneider
Journal:  J Invest Dermatol       Date:  2008-10-02       Impact factor: 8.551

9.  Mesenchymal stem cell 1 (MSC1)-based therapy attenuates tumor growth whereas MSC2-treatment promotes tumor growth and metastasis.

Authors:  Ruth S Waterman; Sarah L Henkle; Aline M Betancourt
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

10.  The possible role of trauma in skin tags through the release of mast cell mediators.

Authors:  Omar S El Safoury; Marwa M Fawzy; Rania M Abdel Hay; Akmal S Hassan; Zeinab M El Maadawi; Laila A Rashed
Journal:  Indian J Dermatol       Date:  2011-11       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.